Myositis in a Patient with Advanced Lung Cancer Treated with Osimertinib

被引：8
|
作者：
Fujioka, Shusei [1 ]
Kitajima, Takamasa [1 ]
Itotani, Ryo [1 ]
机构：
[1] Kitano Hosp, Tazuke Kofukai Med Res Inst, Resp Dis Ctr, Div Resp Med, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 08期
关键词：
D O I：
10.1016/j.jtho.2018.03.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E137 / E139
页数：4
相关论文
共 50 条
  • [31] Osimertinib-induced urticarial vasculitis in a patient with lung cancer: A rare cutaneous toxicity
    Weng, Pei-Chun
    Huang, Yau-Li
    Cheng, Chun-Yu
    EUROPEAN JOURNAL OF CANCER, 2024, 196
  • [32] Atezolizumab-induced myositis in a patient with small-cell lung cancer
    Sahin, Elif
    Cabuk, Devrim
    Kuru, Fatma Tuncer
    Yazici, Ayten
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (01) : 220 - 224
  • [33] Predictive and prognostic values of circulating tumor DNA (ctDNA) clearance in osimertinib treated advanced non-small cell lung cancer cohort
    Song, Yong
    Ma, Shenglin
    Shi, Meiqi
    Xu, Xingxiang
    Chen, Xueqin
    Wang, Yong
    Yang, Zhenhua
    Zhang, Tengfei
    Li, Min
    Li, Haiyan
    Zhang, Lu
    Mao, Xinru
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib
    Buder, Anna
    Hochmair, Maximilian J.
    Setinek, Ulrike
    Pirker, Robert
    Filipits, Martin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) : 239 - +
  • [35] Steroid Resistant, Osimertinib Induced Hypereosinophilic Syndrome (HES) Treated With Benralizumab in a Patient With Metastatic Adenocarcinoma of Lung
    Abid, H.
    Al Torkmani, M.
    Al Kassar, Y.
    Al Maashari, R.
    Gaba, W.
    Athar, S.
    Najib, M.
    Tufail, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [36] Combination of osimertinib and pembrolizumab successfully overcome dual resistances in a patient with advanced adenocarcinoma of the lung, a case report
    Kulendran, Lavenia
    Chia, Puey Ling
    Samol, Jens
    Chang, Alex Y.
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2022, 5
  • [37] Evaluating Osimertinib Induced Pneumonitis in EGFR Advanced Lung Cancer in a Real World Clinical Practice
    Ali, S.
    Nittur, V. R.
    Patel, R. P.
    Hsu, R. C.
    Nieva, J. J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S607 - S607
  • [38] Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
    Soria, J. -C.
    Ohe, Y.
    Vansteenkiste, J.
    Reungwetwattana, T.
    Chewaskulyong, B.
    Lee, K. H.
    Dechaphunkul, A.
    Imamura, F.
    Nogami, N.
    Kurata, T.
    Okamoto, I.
    Zhou, C.
    Cho, B. C.
    Cheng, Y.
    Cho, E. K.
    Voon, P. J.
    Planchard, D.
    Su, W. -C.
    Gray, J. E.
    Lee, S. -M.
    Hodge, R.
    Marotti, M.
    Rukazenkov, Y.
    Ramalingam, S. S.
    Boyer, Michael
    Lee, Chee
    Hughes, Brett
    O'Byrne, Kenneth
    Briggs, Peter
    Milward, Michael
    John, Thomas
    Demedts, Ingel
    Vansteenkiste, Johan
    Bustin, Frederique
    Barrios, Carlos Henrique
    Timcheva, Constanta
    Butts, Charles
    Goss, Glenwood
    Juergens, Rosalyn
    Leighl, Natasha
    Cheng, Susanna
    Burkes, Ronald
    Zhou, Caicun
    Zhang, Helong
    Shu, Yongqian
    Cheng, Ying
    Zhou, Qing
    Li, Wei
    Feng, Guosheng
    He, Yong
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02): : 113 - 125
  • [39] Assessment of minimal residual disease in lung cancer patients treated with osimertinib using liquid biopsy
    Delahaye, Celia
    Casanova, Anne
    Clermont-Tarenchon, Estelle
    Doussine, Aurelia
    Cerapio, Juan-Pablo
    Anton, Anais
    Devienne, Emma
    Dongay, Vincent
    Milia, Julie
    Favre, Gilles
    Calvayrac, Olivier
    Pradines, Anne
    Mazieres, Julien
    CANCER RESEARCH, 2024, 84 (07)
  • [40] Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib
    Kohsuke Masutani
    Kiichiro Fujisaki
    Hiroto Maeda
    Jiro Toyonaga
    Ichiro Inoshima
    Koichi Takayama
    Ritsuko Katafuchi
    Hideki Hirakata
    Kazuhiko Tsuruya
    Mitsuo Iida
    Clinical and Experimental Nephrology, 2008, 12 : 398 - 402
12345